U.S. FDA puts Avidity’s muscle disorder drug trial on partial hold
(Reuters) -Avidity Biosciences Inc said on Tuesday the U.S. Food and Drug Administration has put a hold on patient enrollment in an early-to-mid-stage trial of its drug to treat a…
(Reuters) -Avidity Biosciences Inc said on Tuesday the U.S. Food and Drug Administration has put a hold on patient enrollment in an early-to-mid-stage trial of its drug to treat a…